Home / News / Sponsored: Nicotinell launches ‘New Year, New You’ campaign to support over half of the nation’s smokers looking to quit

Sponsored: Nicotinell launches ‘New Year, New You’ campaign to support over half of the nation’s smokers looking to quit


Facebook
Twitter
LinkedIn

By GSK

06 Jan 2020

Sponsored by GSK

  • With 60% of smokers wanting to quit[1], Nicotinell’s ‘New Year, New You’ campaign is perfectly placed to increase awareness and drive pharmacy sales by supporting consumers on their journey to being smoke free
  • Nicotinell is targeting young smokers looking to quit or reduce smoking by offering education and support
  • Nicotinell offers a range of products and formats designed to suit all shopper types

From January 2020, GSK will be launching a new marketing campaign for smoking cessation support product, Nicotinell. The upcoming ‘New Year, New You’ campaign is intended to assist smokers in cutting down and quitting, with a particular focus on a younger demographic.

The campaign, which will run from January to December 2020, will aim to reach this younger audience through highly targeted digital and social media, offering practical advice and support for smokers throughout their journey to reducing and quitting. The advice will include top tips on getting started, managing cravings and avoiding triggers for relapse.

Nicotinell offers a range of products and formats designed to suit all shopper types. Available in lozenge, gum and patch form, Nicotinell offers a solution to meet any shopper need. Of smokers who quit or cut down on smoking in the past year, 54% either attempted or successfully managed to cut down rather than quit (Nov 2018).; Nicotinell provides an ideal support system.

Eva Pass, Nicotinell brand manager at GSK comments, “Cutting down or quitting smoking is always beneficial – to help people do more, feel better and live longer – and we see a large proportion of smokers choosing January to start or continue their journey to being a non-smoker. Our latest Nicotinell campaign is therefore designed to drive brand awareness and educate customers about the range of smoking cessation options available to them.

“With many shoppers walking away because products are too hard to shop, there is significant headroom to grow the category through education and customer support. Our ‘New Year, New You’ campaign will do exactly that, by targeting customers with simple, tailored content designed to reach the right person, at the right time and with the right message.”

The campaign will be reinforced with physical and digital shelf displays in store, keeping the brand front of mind for shoppers during the crucial New Year’s period. To help pharmacists maximise sales and aid consumers looking for effective smoking cessation support, GSK recommends giving maximum visibility to the Nicotinell brand early on during this key period.

All Nicotinell products are widely available from a range of supermarkets, pharmacies, online stores and the Nicotinell website. For more information on Nicotinell and the range of products available, please visit https://www.nicotinell.co.uk/.

Trademarks are owned by or licensed to the GSK group of companies.

About GSK Consumer Healthcare

GSK Consumer Healthcare is one of the world’s largest consumer healthcare companies, responsible for some of the world’s best loved healthcare brands including Voltarol, Sensodyne, Corsodyl, Panadol, Poligrip and Otrivine.

Product information

All MRSP values are non-RFID and including VAT.

Nicotinell® Mint 2mg/4mg medicated chewing gum (nicotine): Relieve and/or prevent cravings and nicotine withdrawal symptoms associated with tobacco dependence for those wishing to quit or reduce prior to quitting and for smokers unwilling or unable to smoke. Legal category: GSL. Licence holder: GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, 980 Great West Road, Brentford, Middlesex, TW8 9GS

http://www.medicines.org.uk/emc/medicine/20852/SPC/Nicotinell+Mint+2mg++Gum

MRSP:

  • Mint 2mg Gum 96s: £12.95
  • Mint 2mg Gum 204s: £22.30
  • Mint 4mg Gum 96s: £16.08

Nicotinell® Fruit 2mg/4mg medicated chewing gum (nicotine): Relieve and/or prevent cravings and nicotine withdrawal symptoms associated with tobacco dependence for those wishing to quit or reduce prior to quitting and for smokers unwilling or unable to smoke. Legal category: GSL. Licence holder: GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, 980 Great West Road, Brentford, Middlesex, TW8 9GS

http://www.medicines.org.uk/emc/medicine/20833/SPC/Nicotinell+Fruit+2mg++Gum

MRSP:

  • Fruit 2mg Gum 96s: £12.95
  • Fruit 2mg Gum 204s: £22.30
  • Fruit 4mg Gum 96s: £16.08

Nicotinell® Mint 1mg/2mg Lozenge (nicotine): For relief of nicotine withdrawal symptoms as an aid to smoking cessation or temporary smoking reduction in those wanting to quit. Legal category: GSL. Licence holder: GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, 980 Great West Road, Brentford, Middlesex, TW8 9GS

http://www.medicines.org.uk/emc/medicine/13263/SPC/Nicotinell+Mint+1mg++Lozenge/

MRSP:

  • Mint 1mg Lozenge 12s: £2.49
  • Mint 1mg Lozenge 96s: £14.29
  • Mint 1mg Lozenge 144s: £18.00
  • Mint 1mg Lozenge 204s: £20.00
  • Mint 2mg Lozenge 96s: £16.62
  • Mint 2mg Lozenge 144s: £21.00
  • Mint 2mg Lozenge 204s: £23.40

Nicotinell® TTS Patch 10, 20, 30 (nicotine): Relieve and/or prevent cravings and nicotine withdrawal symptoms associated with tobacco dependence for those wishing to quit or reduce prior to quitting and for smokers unwilling or unable to smoke. Legal category: GSL. Licence holder: GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, 980 Great West Road, Brentford, Middlesex, TW8 9GS

http://www.medicines.org.uk/emc/medicine/20064/SPC/Nicotinell+TTS+10/

MRSP:

  • Patch Step 1 7 days: £15.63
  • Patch Step 1 21 days: £38.42
  • Patch Step 2 7 days: £14.74
  • Patch Step 3 7 days: £14.29

[1] https://www.gov.uk/government/publications/health-matters-stopping-smoking-what-works/health-matters-stopping-smoking-what-works


Want news like this straight to your inbox?


Latest News

delivery
Community pharmacists hit out at online pharmacy Facebook ads
Pharmacy professionals have criticised Facebook adverts published by two online pharmacies, claiming they are ‘actively...
Keith Ridge predicts a more ‘clinical future’ for pharmacy post Covid-19
The chief pharmaceutical officer at NHS England has praised pharmacy teams for demonstrating their ‘essential...
covid vaccine trials
Researchers to trial inhaled versions of Covid-19 vaccines
Inhaled versions of two of the UK’s potential Covid-19 vaccines are being trialled in a...